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Abstract To identify genes induced in activated macrophages,
we screened a cDNA library prepared from the lipopolysaccha-
ride (LPS)-treated cell line, RAW264, using the suppression
subtractive hybridization technique. One of the clones isolated
was dramatically induced by LPS in macrophages. The predicted
protein sequence of this gene contains the domain unique to seven
transmembrane receptors, and shows similarity with mouse C-C
chemokine receptor 5 (CCR5). Therefore, we designated it LPS
inducible C-C chemokine receptor related gene (L-CCR).
Northern blot analysis revealed that L-CCR was specifically
expressed in differentiated macrophages after LPS stimulation.
These results show that L-CCR is a novel C-C chemokine
receptor related gene induced by LPS in macrophages and may
play an important role in inflammatory responses.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Macrophages play a central role in host defense against
infection of microbial organisms and invasion of tumor cells
by performing phagocytosis, antigen presentation, tumor cell
killing and so on [1,2]. Macrophages have been shown to be
activated by several in£ammatory mediators. These include
lipopolysaccharide (LPS), an endotoxin derived from Gram-
negative bacteria [3], and cytokines such as IFN-Q [4,5], gran-
ulocyte/macrophage colony stimulating factor [6], tumor ne-
crosis factor-K (TNF-K), and interleukin 1K/L (IL-1K/L) [7].
Among these, LPS is the most potent inducer of the in£am-
matory response for macrophages [8]. Indeed, macrophages,
once activated by LPS, secrete several cytokines, such as mac-
rophage in£ammatory protein-1K/L (MIP-1K/L) [9], IL-6 [10],
TNF-K [11], and IL-1K/L [12], and exhibit enhanced expres-
sion of cell surface antigens such as major histocompatibility
complex II [13,14] and B7-1/2 [15]. These molecules are all
important for the immune and in£ammatory response and
some of them are autocrine macrophage activators. In addi-
tion, several LPS inducible transcription factors, such as
ATF-3 and IRF-1, were identi¢ed from the macrophage cell
line RAW264.7 [16,17].
To isolate novel genes that are induced in activated macro-
phages and responsible for the in£ammatory processes, we
prepared a cDNA library from cultures of the LPS stimulated
mouse macrophage cell line, RAW264, and screened the li-
brary by the suppression subtractive hybridization technique
[18]. One of the cDNA fragments isolated was used for further
study. The isolation and analysis of the full sequence of this
gene revealed that this is a novel molecule which belongs to
the C-C chemokine receptor (CCR) family and we designated
this molecule LPS inducible chemokine receptor related gene
(L-CCR). Northern blot analysis of L-CCR demonstrated
that L-CCR was speci¢cally expressed in the LPS activated
macrophage cell line RAW264. L-CCR was dramatically in-
duced in normal mouse macrophages when stimulated with
LPS. These data indicate that L-CCR may be a chemokine
receptor important for the immune response against microbial
infections.
2. Materials and methods
2.1. Subtractive hybridization and cloning of L-CCR
Subtraction was performed essentially according to the manufactur-
er’s instruction of the PCR-select subtraction kit (Clontech). Brie£y,
1U108 RAW264 cells were stimulated with 100 ng/ml of LPS for 4 h.
Cytoplasmic RNA was obtained from RAW264 cells by guanidine
isothiocyanate-cesium chloride gradient centrifugation [19]. Poly(A)
RNA was puri¢ed using Oligotex-dt30 latex beads (Takara). Comple-
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Fig. 1. Induction of L-CCR expression by LPS. Northern blot anal-
ysis of an LPS induced gene in RAW264 macrophage cell line. Pol-
y(A) RNA (2 mg) from RAW264 cells before (3) and after (+)
LPS stimulation was separated on 1% formaldehyde agarose gel,
transferred to nylon membrane, and hybridized with radiolabeled
PCR fragment of L-CCR (obtained by subtraction). G3PDH is the
internal control.
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mentary DNAs were synthesized from 2 Wg of poly(A) RNA from
RAW264 stimulated with LPS for tester and 2 Wg of poly(A) RNA
from unstimulated RAW264 cells for driver. Following RsaI digestion
of cDNAs, adaptors 1 and 2R were ligated to the tester. Tester cDNA
was hybridized with excess driver cDNA. After hybridization, di¡er-
ential cDNAs were selectively ampli¢ed by suppression PCR. Nested
PCR products were ligated into pGEM-T vector (Promega). A sub-
tracted plasmid library was constructed and independent clones were
ampli¢ed by colony PCR. Di¡erential screening against 500 clones
was performed according to the manufacturer’s instruction (Clon-
tech). Positive clones were sequenced by autosequencer (ABI). Se-
quence comparisons against DDBJ databases as well as protein ho-
mology prediction were obtained from the DDBJ blast server (http://
www.ddbj.nig.ac.jp/E-mail/homology-j.html) [20]. To obtain the full
sequence of di¡erent clones, a cDNA library was constructed from
poly(A) RNA of RAW264 stimulated with 100 ng/ml of LPS for 4 h,
using the ZAP-cDNA Gigapack III gold cloning kit (Stratagene) ac-
cording to the manufacturer’s directions.
The sequences of the obtained clones were determined for both
strands.
2.2. Northern blot analysis
B cell leukemia (BCL-1), myeloma cells (MOPC 315), and thymoma
cells (EL-4) were cultured in RPMI 1640 containing 10% FCS, 100
Wg/ml of streptomycin, 10 U/ml of penicillin G. NK cells (5E3) were
cultured in RPMI 1640 in the presence of 500 U/ml of IL-2 (Gen-
zyme). Monocytic leukemia cells (M1) were cultured in EMEM con-
taining 10% FCS. RAW264 (obtained from Riken cell bank) and
¢broblast cells (NIH 3T3) were cultured in DMEM containing 10%
FCS, 100 Wg/ml streptomycin (Meiji), 10 U/ml of penicillin G (Meiji).
In the case of peritoneal macrophages, C57BL/6 mice were intra-
peritoneally injected with 2 ml of 4% thioglycolate. Three days after
injection, peritoneal exudate cells were elicited by washing the peri-
toneal cavity with 5 ml of ice-cold PBS. Cells were cultured for 2 h
and washed. Adherent cell monolayers were used as peritoneal macro-
phages.
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Fig. 2. L-CCR cDNA sequence and deduced amino acid sequence (DDBJ/GenBank/EMBL accession number AB009384). cDNA sequence of
L-CCR is shown. The short isoform lacks the sequences underlined. Polyadenylation site is in a box. Stop codons are asterisked below.
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Ten million cells were stimulated with 100 ng/ml of LPS, 250 U/ml
of IFN-Q (Genzyme), 1000 U/ml of TNF-K (Genzyme), 400 U/ml of
IL-1L (Genzyme), 1000 U/ml of IL-2, 100 U/ml of IL-4 (Genzyme), or
1000 U/ml of IL-6 (Genzyme) for 4 h.
For time course experiments, ten million cells were harvested after
treatment with 100 ng/ml of LPS for 0^24 h.
Total RNA was extracted using TRIzol reagent (Gibco), electro-
phoresed, transferred to Hybond-N (Amersham) nylon membrane,
and hybridized with the cDNA probe of L-CCR. For L-CCR probe
preparation, full length cDNA was cut with ApaI and EcoRV. The
fragment from nucleotides 551 to 1243 was used as a probe.
3. Results and discussion
To identify LPS inducible genes in macrophages, we utilized
the suppression subtractive hybridization technique based on
PCR ampli¢cation [18]. We stimulated the mouse macrophage
cell line RAW264 with LPS for 4 h, extracted mRNA, and
synthesized double strand cDNA. cDNA from LPS stimu-
lated macrophages was digested with RsaI, ligated to adaptor,
and ampli¢ed by PCR after hybridization with driver cDNA
from non-stimulated macrophages. The resulting PCR prod-
ucts were subcloned and 120 clones were sequenced. As ex-
pected, many cDNA fragments were known genes induced by
LPS stimulation. These include MIP1-K/L, IFN-Q, granulocyte
colony stimulating factor (G-CSF), TNF-K, IL-1L, MIP-2,
inducible nitric oxide synthase (iNOS), cyclooxygenase-2
(COX-2), and interferon inducible protein 10 (IP-10). Besides
the known genes, six clones contained an unknown but iden-
tical sequence. This gene was not expressed in non-stimulated
macrophage cell line RAW264, but dramatically induced by
LPS stimulation (Fig. 1). Northern blot analysis revealed that
this gene has long and short forms of transcript, about 1.9
kbp and 1.4 kbp (Fig. 1). To obtain the full length cDNA of
this gene, we prepared a cDNA library in the VZAPII vector
from RAW264 cells activated by LPS for 4 h, and screened
with the probe of the PCR fragment. Three cDNA clones
were isolated and analyzed. The length of two cDNA clones
obtained was 1877 bp and matched that of the longer band
detected by Northern blot analysis, indicating that this clone
contains the full length cDNA (Fig. 1). This cDNA clone has
an open reading frame of 1080 bp encoding a protein of 360
amino acids (Fig. 2) (the nucleotide sequence data reported in
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Fig. 3. Alignment of L-CCR protein sequence against human CKRX and mouse CCR5. Putative transmembrane domains are overlined (TM
1^7) and identical amino acid residues are highlighted with solid boxes.
Fig. 4. Expression of L-CCR mRNA in several hematopoietic cell
lines and mouse peritoneal macrophages. Indicated cell lines and
mouse peritoneal macrophages (PEC) were stimulated with 100 ng/
ml of LPS for 4 h. Total RNA (25 Wg/lane; 20 Wg/lane for PEC)
from stimulated (+) or non-stimulated (3) cells was separated on
1% formaldehyde agarose gel, transferred to nylon membrane, and
hybridized with radiolabeled L-CCR cDNA fragment. The lower
column shows ethidium bromide stained ribosomal RNA of the
upper column.
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this paper will appear in the DDBJ, EMBL and GenBank
nucleotide sequence databases with accession number
AB009384). It has the putative initiating methionine with
the consensus Kozak sequence and the preceding in-frame
stop codon [21]. In the 3P untranslated region, a typical poly-
adenylation signal, AATAAA, was found upstream of the
poly(A) tail. An additional clone also contained the same
coding region and poly(A) tail, but 513 bp of nucleotides in
the 3P untranslated region were absent (Fig. 2). The length of
this clone matched the shorter band detected by Northern blot
analysis. This shorter cDNA may be a product of alternative
polyadenylation signal usage of the L-CCR, using an atypical
polyadenylation signal, AATATA, existing upstream of the
poly(A) tail.
The deduced amino acid sequence of this gene shares sig-
ni¢cant sequence identity with the known C-C chemokine
receptors, containing the characteristic domain of seven trans-
membrane receptors (Fig. 3). It is most similar to mouse
CCR5 (DDBJ/GenBank accession number AF019772) with
35.8% identity and shares 34.9% identity with mouse CCR1
(DDBJ/GenBank/EMBL accession number U29678) at the
amino acid level. Therefore, we named this gene LPS induci-
ble C-C chemokine receptor related gene (L-CCR). In addi-
tion, homology search using the DDBJ blast system revealed
that a recently deposited novel human chemokine receptor,
designated human chemokine receptor x (CKRX) (DDBJ/
GenBank accession number AF014958), showed 51.1% ho-
mology with mouse L-CCR at the amino acid level (Fig. 3).
This implied that the L-CCR may be a mouse homologue of
the human CKRX. Thus, we identi¢ed and molecularly
cloned a novel mouse CCR family member, which is induced
by LPS in macrophages.
To examine the expression pro¢le of L-CCR, we performed
Northern blot analysis of mRNA in several types of cell lines
before and after LPS stimulation. Abundant expression of
mRNA of the expected size was observed in LPS activated
RAW264. In cell lines such as M1 (myeloid leukemia cells),
BCL-1 (B cell leukemia cells), MOPC 315 (myeloma cells),
EL-4 (T-cells), 5E3 (NK cells), and NIH 3T3 (¢broblast cells),
expression of L-CCR mRNA was not detected before and
after LPS stimulation (Fig. 4). Weak expression was observed
in thioglycolate elicited peritoneal macrophages, and its ex-
pression was dramatically increased by LPS stimulation
(Fig. 4). These results demonstrate that L-CCR is not ex-
pressed in lymphoid cells but is induced by LPS in di¡erenti-
ated monocytes/macrophages. Several recent ¢ndings have
demonstrated that chemokine receptor expression is regulated
by LPS, for example, CCR2, CCR1, and CCR5 are expressed
in resident monocytes/macrophages and down-regulated by
LPS [22,23]. In addition, the combination of LPS and TNF-
K inhibited the expression of the IL-8 receptor in neutrophils
[22]. So far, there have been no reports about upregulation of
the chemokine receptor in response to LPS. Therefore, L-
CCR may be the ¢rst chemokine receptor which is upregu-
lated by LPS.
Besides LPS, several in£ammatory cytokines such as IFN-Q,
TNF-K, and IL-1 have been shown to a¡ect macrophage ac-
tivities. In addition, IL-2 has been shown to upregulate the
expression of CCR2 or CCR5 in macrophages [22,23]. There-
fore, we next analyzed the expression of L-CCR in response
to these cytokines in RAW264. As shown in Fig. 5, expression
of L-CCR mRNA was not induced by stimulation with IFN-
Q, TNF-K, IL-1L, IL-2, IL-4, or IL-6. These data demonstrate
that L-CCR is speci¢cally induced by LPS stimulation in the
RAW264 macrophage cell line.
In order to analyze the time course of accumulation of L-
CCR mRNA, RAW264 cells were harvested after treatment
with LPS for 0^24 h. As indicated in Fig. 6, L-CCR was
induced by 30 min, reaching a peak at 2 h.
In conclusion, we identi¢ed a novel CCR related gene, L-
CCR, by the suppression subtractive hybridization method.
Contrary to other CCR families, L-CCR is not expressed in
non-stimulated cells, but is dramatically induced by LPS stim-
ulation in macrophages, demonstrating that L-CCR is the
LPS inducible gene in macrophages. In addition, time course
analysis revealed that the induction of L-CCR was quite rapid
and L-CCR could be classi¢ed as an immediate early gene.
Therefore, L-CCR may play an important role in controlling
bacterial infection. Further study, such as identi¢cation of its
ligands and generation of L-CCR de¢cient mice, will delineate
the precise role of L-CCR in vivo.
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Fig. 5. Induction of L-CCR with several cytokines. RAW264 cells
were stimulated with the indicated reagents for 4 h. Total RNA (25
Wg/lane) was separated on 1% formaldehyde agarose gel, transferred
to nylon membrane, and hybridized with radiolabeled L-CCR
cDNA fragment. The lower column shows ethidium bromide stained
ribosomal RNA of the upper column.
Fig. 6. Time course of L-CCR mRNA in RAW264 cells. RAW264
cells were treated with 100 ng/ml of LPS for 0^24 h as noted.
Northern blot analysis was performed as described in the legend of
Fig. 5. G3PHD is the internal control.
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